- Home
- NKTR vs SRG Comparison
NKTR vs SRG Comparison
Compare NKTR & SRG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NKTR
- SRG
- Stock Information
- Founded
- NKTR 1990
- SRG 2014
- Country
- NKTR United States
- SRG United States
- Employees
- NKTR N/A
- SRG N/A
- Industry
- NKTR Biotechnology: Pharmaceutical Preparations
- SRG Real Estate Investment Trusts
- Sector
- NKTR Health Care
- SRG Real Estate
- Exchange
- NKTR Nasdaq
- SRG Nasdaq
- Market Cap
- NKTR 238.7M
- SRG 254.9M
- IPO Year
- NKTR 1994
- SRG 2015
- Fundamental
- Price
- NKTR $1.32
- SRG $4.63
- Analyst Decision
- NKTR Buy
- SRG
- Analyst Count
- NKTR 4
- SRG 0
- Target Price
- NKTR $2.50
- SRG N/A
- AVG Volume (30 Days)
- NKTR 988.9K
- SRG 249.9K
- Earning Date
- NKTR 11-05-2024
- SRG 11-06-2024
- Dividend Yield
- NKTR N/A
- SRG N/A
- EPS Growth
- NKTR N/A
- SRG N/A
- EPS
- NKTR N/A
- SRG N/A
- Revenue
- NKTR $93,157,000.00
- SRG $59,030,000.00
- Revenue This Year
- NKTR N/A
- SRG N/A
- Revenue Next Year
- NKTR N/A
- SRG N/A
- P/E Ratio
- NKTR N/A
- SRG N/A
- Revenue Growth
- NKTR 6.17
- SRG 274.65
- 52 Week Low
- NKTR $0.41
- SRG $3.63
- 52 Week High
- NKTR $1.93
- SRG $9.87
- Technical
- Relative Strength Index (RSI)
- NKTR 56.07
- SRG 53.82
- Support Level
- NKTR $1.11
- SRG $4.45
- Resistance Level
- NKTR $1.39
- SRG $4.76
- Average True Range (ATR)
- NKTR 0.09
- SRG 0.13
- MACD
- NKTR 0.01
- SRG 0.01
- Stochastic Oscillator
- NKTR 75.00
- SRG 67.44
About NKTR Nektar Therapeutics
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pipeline of investigational medicines in oncology, immunology, and virology as well as a portfolio of approved partnered medicines. In oncology, The company is focused on activating the immune system natural tumor-fighting mechanisms, and it will be studying several immuno-oncology drug candidates in the clinic for a variety of cancer indications. In immunology, it is focused on addressing imbalances in the immune system to restore the body's self-tolerance mechanisms and achieve immune homeostasis. In virology, the company believes selective immuno-modulators can be useful in addressing viral infections in people. The group derives revenue from the United States and the Rest of the World.
About SRG Seritage Growth Properties
Seritage Growth Properties is principally engaged in the ownership, development, redevelopment, management and leasing of diversified and mixed-use properties throughout the United States.